- Home
- CMP vs PRME Comparison
CMP vs PRME Comparison
Compare CMP & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMP
- PRME
- Stock Information
- Founded
- CMP 1993
- PRME 2019
- Country
- CMP United States
- PRME United States
- Employees
- CMP N/A
- PRME N/A
- Industry
- CMP Other Metals and Minerals
- PRME Medicinal Chemicals and Botanical Products
- Sector
- CMP Basic Materials
- PRME Health Care
- Exchange
- CMP Nasdaq
- PRME Nasdaq
- Market Cap
- CMP 493.5M
- PRME 191.7M
- IPO Year
- CMP 2003
- PRME 2022
- Fundamental
- Price
- CMP $20.20
- PRME $2.47
- Analyst Decision
- CMP Buy
- PRME Buy
- Analyst Count
- CMP 3
- PRME 6
- Target Price
- CMP $19.00
- PRME $9.38
- AVG Volume (30 Days)
- CMP 674.3K
- PRME 3.1M
- Earning Date
- CMP 05-07-2025
- PRME 08-04-2025
- Dividend Yield
- CMP N/A
- PRME N/A
- EPS Growth
- CMP N/A
- PRME N/A
- EPS
- CMP N/A
- PRME N/A
- Revenue
- CMP $1,213,500,000.00
- PRME $3,846,000.00
- Revenue This Year
- CMP $11.69
- PRME $104.12
- Revenue Next Year
- CMP $0.96
- PRME $196.78
- P/E Ratio
- CMP N/A
- PRME N/A
- Revenue Growth
- CMP 5.81
- PRME 550.76
- 52 Week Low
- CMP $7.51
- PRME $1.11
- 52 Week High
- CMP $20.96
- PRME $6.75
- Technical
- Relative Strength Index (RSI)
- CMP 60.07
- PRME 79.86
- Support Level
- CMP $19.19
- PRME $1.56
- Resistance Level
- CMP $20.06
- PRME $2.53
- Average True Range (ATR)
- CMP 0.76
- PRME 0.25
- MACD
- CMP -0.17
- PRME 0.12
- Stochastic Oscillator
- CMP 60.00
- PRME 99.21
About CMP Compass Minerals Intl Inc
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.